Vext Science, Inc. ( VEXTF) - Key Metrics
VEXTF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | ? | ? | ? | ? |
| 2025Q3 | ? | ? | ? | ? |
| 2025Q2 | $0.05 | -$0.01 | $0.02 | $0.01 |
| 2025Q1 | $0.05 | -$0.01 | $0.01 | $0.01 |
VEXTF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | ? |
| 2025Q3 | ? | ? |
| 2025Q2 | ? | -5.26 |
| 2025Q1 | ? | -2.32 |
VEXTF Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | 2.68% | ? |
| 2025Q4 | 6.75% | ? |
| 2025Q3 | 0.21% | ? |
| 2025Q2 | 10.92% | ? |
| 2025Q1 | 7.33% | ? |
VEXTF
Price: $0.18
52 week price:
Earnings Per Share: -0.07 USD
P/E Ratio: -2.57
Exchange: OQX
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 40.4 million